ZNF114
gene geneOn this page
Also known as MGC17986
Summary
ZNF114 (zinc finger protein 114, HGNC:12894) is a protein-coding gene on chromosome 19q13.33, encoding Zinc finger protein 114 (Q8NC26). May be involved in transcriptional regulation.
Enables identical protein binding activity. Predicted to be involved in regulation of DNA-templated transcription. Located in extracellular exosome.
Source: NCBI Gene 163071 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 63 total
- MANE Select transcript:
NM_153608
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:12894 |
| Approved symbol | ZNF114 |
| Name | zinc finger protein 114 |
| Location | 19q13.33 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC17986 |
| Ensembl gene | ENSG00000178150 |
| Ensembl biotype | protein_coding |
| OMIM | 603996 |
| Entrez | 163071 |
Gene structure
Transcript identifiers
Ensembl transcripts: 13 — 12 protein_coding, 1 retained_intron
ENST00000315849, ENST00000594024, ENST00000595408, ENST00000595607, ENST00000598898, ENST00000600687, ENST00000601320, ENST00000888399, ENST00000888400, ENST00000912946, ENST00000912947, ENST00000912948, ENST00000912949
RefSeq mRNA: 5 — MANE Select: NM_153608
NM_001331097, NM_001331098, NM_001369811, NM_001369812, NM_153608
CCDS: CCDS12713
Canonical transcript exons
ENST00000595607 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001254628 | 48279731 | 48279808 |
| ENSE00001254633 | 48271727 | 48271828 |
| ENSE00002992897 | 48271245 | 48271449 |
| ENSE00003033654 | 48285761 | 48287608 |
| ENSE00003061583 | 48270081 | 48270219 |
| ENSE00003640483 | 48282371 | 48282497 |
Expression profiles
Bgee: expression breadth ubiquitous, 159 present calls, max score 97.83.
FANTOM5 (CAGE): breadth broad, TPM avg 1.9679 / max 109.7254, expressed in 575 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 176755 | 1.3867 | 557 |
| 176754 | 0.5812 | 109 |
Top tissues by expression
246 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| buccal mucosa cell | CL:0002336 | 97.83 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 78.01 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 77.00 | gold quality |
| endothelial cell | CL:0000115 | 74.67 | silver quality |
| ventricular zone | UBERON:0003053 | 72.16 | gold quality |
| ganglionic eminence | UBERON:0004023 | 69.06 | gold quality |
| thyroid gland | UBERON:0002046 | 68.84 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 68.82 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 68.23 | gold quality |
| cortical plate | UBERON:0005343 | 68.20 | gold quality |
| placenta | UBERON:0001987 | 63.26 | gold quality |
| calcaneal tendon | UBERON:0003701 | 62.18 | gold quality |
| hypothalamus | UBERON:0001898 | 60.42 | gold quality |
| amygdala | UBERON:0001876 | 59.09 | gold quality |
| pigmented layer of retina | UBERON:0001782 | 59.08 | silver quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 58.97 | gold quality |
| endometrium | UBERON:0001295 | 58.65 | gold quality |
| spinal cord | UBERON:0002240 | 57.26 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 57.17 | gold quality |
| adrenal tissue | UBERON:0018303 | 57.00 | gold quality |
| prefrontal cortex | UBERON:0000451 | 55.85 | gold quality |
| endocervix | UBERON:0000458 | 55.22 | gold quality |
| right coronary artery | UBERON:0001625 | 55.17 | gold quality |
| tendon | UBERON:0000043 | 54.93 | gold quality |
| mucosa of stomach | UBERON:0001199 | 54.78 | gold quality |
| nucleus accumbens | UBERON:0001882 | 54.59 | gold quality |
| vermiform appendix | UBERON:0001154 | 54.42 | gold quality |
| body of pancreas | UBERON:0001150 | 54.33 | gold quality |
| uterus | UBERON:0000995 | 54.00 | gold quality |
| caudate nucleus | UBERON:0001873 | 53.99 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 4.17 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): STAT1
miRNA regulators (miRDB)
30 targeting ZNF114, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5193 | 100.00 | 67.26 | 1744 |
| HSA-MIR-4481 | 100.00 | 66.42 | 1669 |
| HSA-MIR-6833-3P | 100.00 | 70.63 | 3197 |
| HSA-MIR-4768-5P | 100.00 | 69.49 | 2861 |
| HSA-MIR-513A-5P | 100.00 | 69.77 | 2465 |
| HSA-MIR-4745-5P | 99.98 | 65.95 | 1028 |
| HSA-MIR-6778-3P | 99.96 | 67.29 | 2693 |
| HSA-MIR-23A-3P | 99.95 | 74.24 | 3163 |
| HSA-MIR-23B-3P | 99.95 | 74.24 | 3163 |
| HSA-MIR-23C | 99.95 | 73.92 | 3192 |
| HSA-MIR-145-5P | 99.92 | 71.13 | 1836 |
| HSA-MIR-5195-3P | 99.92 | 70.92 | 1877 |
| HSA-MIR-3686 | 99.90 | 70.53 | 2432 |
| HSA-MIR-3618 | 99.69 | 68.57 | 1012 |
| HSA-MIR-3685 | 99.62 | 68.83 | 1621 |
| HSA-MIR-4743-3P | 99.62 | 68.12 | 2095 |
| HSA-MIR-17-3P | 99.55 | 66.77 | 1311 |
| HSA-MIR-150-3P | 99.43 | 70.51 | 920 |
| HSA-MIR-4652-3P | 99.33 | 70.02 | 2742 |
| HSA-MIR-3160-5P | 99.28 | 69.07 | 1938 |
| HSA-MIR-7151-3P | 99.04 | 69.72 | 2370 |
| HSA-MIR-155-3P | 99.03 | 67.99 | 924 |
| HSA-MIR-3124-3P | 98.87 | 68.95 | 2123 |
| HSA-MIR-934 | 98.49 | 70.44 | 581 |
| HSA-MIR-4726-3P | 98.49 | 63.89 | 1385 |
| HSA-MIR-4294 | 97.86 | 65.72 | 1110 |
| HSA-MIR-4724-3P | 97.57 | 67.31 | 785 |
| HSA-MIR-12128 | 96.67 | 66.98 | 1471 |
| HSA-MIR-1238-5P | 94.82 | 67.52 | 493 |
| HSA-MIR-4758-5P | 94.82 | 67.06 | 499 |
Cross-species orthologs
1 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | ENSDARG00000099025 |
Paralogs (18): ZNF430 (ENSG00000118620), ZNF92 (ENSG00000146757), ZNF66 (ENSG00000160229), ZNF22 (ENSG00000165512), ZNF680 (ENSG00000173041), ZFP41 (ENSG00000181638), ZNF730 (ENSG00000183850), ZNF479 (ENSG00000185177), ZNF626 (ENSG00000188171), ZNF431 (ENSG00000196705), ZNF100 (ENSG00000197020), ZNF257 (ENSG00000197134), ZNF98 (ENSG00000197360), ZNF675 (ENSG00000197372), ZNF273 (ENSG00000198039), ZNF737 (ENSG00000237440), ZNF253 (ENSG00000256771), ZNF723 (ENSG00000268696)
Protein
Protein identifiers
Zinc finger protein 114 — Q8NC26 (reviewed: Q8NC26)
All UniProt accessions (4): Q8NC26, M0QXN8, M0R0H2, M0R0V4
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8NC26-1 | 1 | yes |
| Q8NC26-2 | 2 |
RefSeq proteins (5): NP_001318026, NP_001318027, NP_001356740, NP_001356741, NP_705836* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF01352, PF13465
UniProt features (12 total): zinc finger region 4, sequence variant 2, region of interest 2, chain 1, domain 1, compositionally biased region 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NC26-F1 | 45.90 | 0.01 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 33 (showing top):
GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8_TCELL_IFNAR_KO_UP, GSE45365_CTRL_VS_MCMV_INFECTION_NK_CELL_DN, CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1, GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN, GEORGES_TARGETS_OF_MIR192_AND_MIR215, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, KRIEG_HYPOXIA_NOT_VIA_KDM3A, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, CBX5_TARGET_GENES, CBX7_TARGET_GENES, ZNF350_TARGET_GENES, ZNF362_TARGET_GENES, ZNF512_TARGET_GENES, ZNF512B_TARGET_GENES
GO Biological Process (2): regulation of DNA-templated transcription (GO:0006355), regulation of transcription by RNA polymerase II (GO:0006357)
GO Molecular Function (7): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), identical protein binding (GO:0042802), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (2): nucleus (GO:0005634), extracellular exosome (GO:0070062)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| protein binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| extracellular vesicle | 1 |
Protein interactions and networks
STRING
320 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF114 | VWCE | Q96DN2 | 474 |
| ZNF114 | FBXW10B | O95170 | 470 |
| ZNF114 | MAN1C1 | Q9NR34 | 418 |
| ZNF114 | CMBL | Q96DG6 | 402 |
| ZNF114 | GRHL2 | Q6ISB3 | 380 |
| ZNF114 | CSGALNACT1 | Q8TDX6 | 329 |
| ZNF114 | RNF114 | Q9Y508 | 325 |
| ZNF114 | N4BP2L1 | Q5TBK1 | 324 |
| ZNF114 | ANKFN1 | Q8N957 | 319 |
| ZNF114 | NSA2 | O95478 | 315 |
| ZNF114 | TRIM36 | Q9NQ86 | 314 |
| ZNF114 | AMER2 | Q8N7J2 | 314 |
| ZNF114 | LMBR1L | Q6UX01 | 312 |
| ZNF114 | ERVV-2 | B6SEH9 | 311 |
| ZNF114 | MAGEC3 | Q8TD91 | 303 |
IntAct
49 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CLIP4 | ZNF114 | psi-mi:“MI:0915”(physical association) | 0.780 |
| KLHL2 | ZNF114 | psi-mi:“MI:0915”(physical association) | 0.780 |
| ZNF114 | CLIP4 | psi-mi:“MI:0915”(physical association) | 0.780 |
| ZNF114 | KLHL2 | psi-mi:“MI:0915”(physical association) | 0.780 |
| ZNF114 | ZNF114 | psi-mi:“MI:0915”(physical association) | 0.670 |
| KIAA0753 | ZNF114 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF114 | KIAA0753 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF114 | TPPP | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF114 | MAP7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF114 | SUFU | psi-mi:“MI:0915”(physical association) | 0.560 |
| MYO15B | ZNF114 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TPPP | ZNF114 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MAP7 | ZNF114 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CENATAC | ZNF114 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF8 | ZNF114 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP10-6 | ZNF114 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TRIM28 | ZNF320 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNF114 | PPP2R1A | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF566 | IPO8 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (37): ZNF114 (Two-hybrid), ZNF114 (Two-hybrid), ZNF114 (Two-hybrid), ZNF114 (Two-hybrid), TRIM28 (Affinity Capture-MS), PPP2R1B (Affinity Capture-MS), PPP2R1A (Affinity Capture-MS), CBX5 (Affinity Capture-MS), PPP2R2C (Affinity Capture-MS), PPP2CA (Affinity Capture-MS), CUEDC1 (Affinity Capture-MS), ZNF114 (Affinity Capture-MS), CUEDC1 (Affinity Capture-MS), PPP2R2C (Affinity Capture-MS), PPP2CA (Affinity Capture-MS)
ESM2 similar proteins: A0JPL0, A1L1L7, A7MBI1, A8MT65, B2RXC5, G3X9G7, P0CG31, P21506, P52738, Q02525, Q2KI58, Q2M3W8, Q49AA0, Q4R6J4, Q5FWF6, Q5RB33, Q5RCJ2, Q5RE50, Q5REF1, Q5T5D7, Q5VIY5, Q6V9R5, Q6ZMW2, Q6ZN11, Q6ZNG0, Q86TJ5, Q86XU0, Q8BGV5, Q8N782, Q8N859, Q8N883, Q8N9Z0, Q8NC26, Q8NE65, Q95K49, Q96N20, Q96NG8, Q96NJ3, Q96SR6, Q9BSK1
Diamond homologs: A2RRD8, A6NFI3, A6NM28, A8MUZ8, A8MWA4, B2RUI1, B4DU55, E9Q8G5, O43296, O43361, O75467, O75820, P0CH99, P0CI00, P10078, P16373, P16374, P17021, P17023, P17032, P17097, P17098, P21506, P51786, P52740, Q06732, Q08ER8, Q13106, Q13360, Q13398, Q14592, Q147U1, Q32M78, Q3KQV3, Q3MIS6, Q3SY52, Q571J5, Q5CZA5, Q5HY98, Q5R7I8
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
63 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 56 |
| Likely benign | 3 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
766 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:48270215:GCATA:G | donor_gain | 1.0000 |
| 19:48270220:G:GG | donor_gain | 1.0000 |
| 19:48271445:GGGGA:G | donor_gain | 1.0000 |
| 19:48271446:GGGAG:G | donor_gain | 1.0000 |
| 19:48271447:GGA:G | donor_gain | 1.0000 |
| 19:48271448:GAG:G | donor_gain | 1.0000 |
| 19:48271450:G:GG | donor_gain | 1.0000 |
| 19:48271463:G:GT | donor_gain | 1.0000 |
| 19:48271464:A:T | donor_gain | 1.0000 |
| 19:48271829:G:GG | donor_gain | 1.0000 |
| 19:48279729:A:AG | acceptor_gain | 1.0000 |
| 19:48279730:G:GG | acceptor_gain | 1.0000 |
| 19:48282365:TTTTA:T | acceptor_loss | 1.0000 |
| 19:48282366:TTTA:T | acceptor_loss | 1.0000 |
| 19:48282367:TTAG:T | acceptor_loss | 1.0000 |
| 19:48282368:TAGG:T | acceptor_loss | 1.0000 |
| 19:48282369:A:AG | acceptor_gain | 1.0000 |
| 19:48282369:AG:A | acceptor_gain | 1.0000 |
| 19:48282370:G:GC | acceptor_loss | 1.0000 |
| 19:48282370:G:GG | acceptor_gain | 1.0000 |
| 19:48282370:GG:G | acceptor_gain | 1.0000 |
| 19:48282370:GGA:G | acceptor_gain | 1.0000 |
| 19:48282495:TAG:T | donor_gain | 1.0000 |
| 19:48282496:AG:A | donor_gain | 1.0000 |
| 19:48282497:GG:G | donor_gain | 1.0000 |
| 19:48282498:G:C | donor_loss | 1.0000 |
| 19:48282498:G:GG | donor_gain | 1.0000 |
| 19:48282499:T:G | donor_loss | 1.0000 |
| 19:48285759:A:AG | acceptor_gain | 1.0000 |
| 19:48285760:G:GG | acceptor_gain | 1.0000 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000291817 (19:48277490 T>C), RS1000617838 (19:48276335 T>C), RS1000849279 (19:48271094 G>A), RS1000852077 (19:48281378 C>A), RS1000874244 (19:48273411 TTTTTC>T,TTTTTCTTTTC), RS1000902189 (19:48275799 G>A), RS1000945850 (19:48268104 A>G), RS1001020847 (19:48286958 G>A), RS1001125520 (19:48269109 C>A), RS1001309535 (19:48277147 T>A), RS1001549211 (19:48282345 G>A,C), RS1001562229 (19:48270180 G>A,C), RS1001605865 (19:48270648 G>A,C), RS1001611767 (19:48276935 G>T), RS1001735047 (19:48276669 G>A)
Disease associations
OMIM: gene MIM:603996 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
40 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | increases expression, increases methylation | 5 |
| Estradiol | affects binding, increases expression | 3 |
| Valproic Acid | affects expression, decreases expression, increases methylation | 3 |
| sodium arsenite | increases expression | 2 |
| Cisplatin | affects cotreatment, increases expression | 2 |
| Cyclosporine | increases expression, decreases expression | 2 |
| Aflatoxin B1 | affects expression, increases methylation | 2 |
| Cadmium Chloride | increases expression | 2 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| dimethylselenide | increases expression, increases oxidation | 1 |
| mono-(2-ethylhexyl)phthalate | increases abundance, decreases methylation | 1 |
| S-(1,2-dichlorovinyl)cysteine | affects response to substance, increases expression | 1 |
| abrine | decreases expression | 1 |
| perfluorobutanesulfonic acid | decreases expression | 1 |
| jinfukang | increases expression, affects cotreatment | 1 |
| 2,3,5-trichloro-6-phenyl-(1,4)benzoquinone | decreases expression | 1 |
| Arsenic Trioxide | increases expression | 1 |
| Leflunomide | increases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Cadmium | increases expression | 1 |
| Calcitriol | increases expression | 1 |
| Dichlorodiphenyl Dichloroethylene | decreases expression | 1 |
| Diethylhexyl Phthalate | decreases methylation, increases abundance | 1 |
| Hydrogen Peroxide | affects expression | 1 |
| Lipopolysaccharides | affects response to substance, increases expression, decreases expression | 1 |
| Ozone | increases expression, increases oxidation | 1 |
| Quercetin | affects expression | 1 |
| Silicon Dioxide | increases expression | 1 |
| Tetrachlorodibenzodioxin | decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_XW03 | HEK293 eGFP-ZNF114 | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.